ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626176 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626176; 2) Community: the network communities that were significantly associated with the response to NSC 626176; 3) Molecule: the relationships between components within communities and NSC 626176; 4) MDR: the compounds that were significantly associated with the NSC 626176.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.022188614181866 0.082841979
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.022188614181866 0.15825318
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.022188614181866 -0.11506765
NSC 300289 Pinafide 0.022188614181866 -0.051074733
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.022188614181866 0.2985842
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.022188614181866 0.20221583
NSC 56054 Pseudourea, 2,2'-(9,10-anthrylenedimethylene)bis(2-thio-, dihydrochloride, dihydrate 0.022188614181866 0.20633966
NSC 603071 Aminocamptothecin 0.022188614181866 -0.045389714
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.022188614181866 0.13446508
NSC 606497 Camptothecin Derivative 0.022188614181866 -0.061274541
Total:85  Current:43    [First] [Prev] [Next] [Last]